Vestibular Rehabilitation Success Rate: What Results Are Realistic?

Quick answer: There is no single, trustworthy “vestibular rehabilitation success rate” for every patient. Results depend on the diagnosis, the impairment being treated, the outcome measured, the programme, supervision, other health conditions and follow-up. Evidence strongly supports vestibular rehabilitation therapy (VRT) for appropriately diagnosed peripheral vestibular hypofunction, but that evidence should not be converted into a universal percentage or a guaranteed recovery time.

Evidence reviewed/updated: 30 August 2026.

Why one VRT success percentage is misleading

Studies define “success” in different ways. Some measure dizziness-related disability; others measure gaze stability, balance, walking, falls, confidence or return to daily activity. A patient may improve substantially in function while still having some symptoms. Conversely, a lower symptom score does not automatically mean that driving, working at height or walking without support is safe.

The original version of this article listed one overall success rate, separate percentages for several diagnoses, fixed recovery milestones and compliance-based outcome tiers. The cited research does not support those universal numbers. The safer interpretation is diagnosis-specific and outcome-based.

What the strongest evidence shows

Peripheral vestibular hypofunction

The 2022 clinical practice guideline from the Academy of Neurologic Physical Therapy concluded that there is strong evidence for VRT in adults with diagnosed unilateral or bilateral peripheral vestibular hypofunction. Programmes may include gaze-stabilisation, balance, walking, habituation and functional exercises selected for the patient’s findings. The guideline also notes that older adults can achieve good outcomes and that people with chronic symptoms may still improve; age or a delayed start should not be turned into a fixed numerical penalty.

The guideline’s recommendations do not automatically apply to undiagnosed dizziness or every central neurological disorder. A correct diagnosis and an individual safety assessment remain essential. Hall et al., 2022 guideline (PubMed 34864777).

Systematic-review evidence

The corrected 2015 Cochrane review included 39 studies with 2,441 participants who had unilateral peripheral vestibular disorders. It found evidence that exercise-based vestibular rehabilitation improved dizziness and function compared with control or usual care. The studies differed in diagnoses, interventions and outcome measures, and the review did not establish a universal 70–80% success rate or prove that one rehabilitation format is best for everyone.

For BPPV, canal-repositioning procedures produced better short-term results than exercise-based VRT. That distinction matters: a repositioning manoeuvre is a diagnosis- and canal-specific treatment, not evidence for a general VRT success percentage. McDonnell and Hillier, 2015 (PubMed 25581507).

What individual trials can and cannot tell us

Individual trials show why a single headline percentage is unreliable. In a 12-week randomized trial involving people with unilateral or bilateral vestibular hypofunction, 86 of 124 enrolled participants completed the programme and 52 completers showed clear locomotor gains. Another randomized trial of 42 adults with chronic unilateral vestibular dysfunction found that a four-week customised programme improved dizziness, disability, balance and postural stability compared with no treatment. These studies support benefit in selected populations, but their endpoints and populations are not interchangeable.

• Krebs et al., 2003 (PubMed 12601321)
• Giray et al., 2009 (PubMed 19651266)

Results differ by diagnosis

Unilateral vestibular hypofunction and vestibular neuritis

VRT can support central compensation, gaze stability, balance and walking after unilateral vestibular loss. Improvement may continue over weeks or months, but no online percentage can predict an individual result. Persistent or changing symptoms need reassessment because incomplete compensation, another vestibular disorder, migraine, medication effects or a neurological condition may alter the plan.

Bilateral vestibular hypofunction

The 2022 guideline recommends VRT for bilateral peripheral vestibular hypofunction, but treatment goals and the degree of recovery vary. Some patients continue to have difficulty in darkness, on uneven ground or during rapid head movement. Rehabilitation may improve safety and function without restoring normal vestibular organ function.

BPPV

Typical BPPV is primarily treated with the appropriate canal-repositioning manoeuvre after the affected side and canal are identified. VRT may be considered when imbalance persists or another vestibular deficit is present, but generic exercises should not replace canal-specific treatment. The Dix–Hallpike test is a diagnostic positional test; it is not a repositioning treatment.

Vestibular migraine and PPPD

VRT may be one part of care for selected patients with vestibular migraine, visual-motion sensitivity or persistent postural-perceptual dizziness (PPPD). These diagnoses require their own clinical criteria and often need a broader plan. Exercise progression may need careful pacing, and rehabilitation results should not be expressed using a percentage borrowed from peripheral hypofunction studies.

Central neurological disorders

People with stroke, multiple sclerosis, cerebellar disease, traumatic brain injury or another central disorder may receive condition-specific rehabilitation. The peripheral-hypofunction guideline does not establish a general success rate for these conditions. Goals, precautions and prognosis should be set with the relevant neurology and rehabilitation team.

How meaningful VRT progress is measured

Before starting, the clinician and patient should agree on measurable goals. Depending on the diagnosis, useful outcomes may include:

• lower dizziness-related disability on a validated questionnaire;
• better gaze stability during head movement;
• safer standing, turning, walking and transfers;
• fewer falls or near-falls;
• greater tolerance of busy visual environments;
• return to selected daily activities with appropriate safety; and
• less need for support from another person.

Return to driving, machinery, heights or safety-critical work needs an individual assessment. Improvement on one clinic scale does not by itself establish fitness for those activities.

How long should improvement take?

There is no universal sequence of “early improvement at two weeks, recovery at twelve weeks and a plateau by four months.” The expected course depends on whether the problem is acute or chronic, unilateral or bilateral, peripheral or central, and whether there is BPPV, migraine, neuropathy, visual impairment, anxiety, neck or joint limitation, cognitive difficulty or fall risk.

A prescribed home programme is important, but the exercises and dose should match the diagnosis and response. Severe or prolonged worsening is not proof that the programme is working. Review is appropriate when symptoms worsen, new features appear, falls occur, the exercises cannot be performed safely, or progress does not match the treating clinician’s plan.

Factors that may influence outcome

• Diagnostic accuracy: VRT cannot correct a treatment plan aimed at the wrong disorder.
• Programme specificity: gaze, balance, habituation and walking exercises address different impairments.
• Supervision and safe progression: some patients need closer review because of falls, severe symptoms or comorbidity.
• Other health conditions: migraine, neuropathy, vision, musculoskeletal limitation, cognition and medicines may affect the plan.
• Participation: following the agreed programme matters, but no evidence supports the old 85%, 70%, 45% and 20% compliance tiers.

August 2026 evidence update

Two August 2026 studies add useful—but limited—information. Neither validates a universal VRT success rate.

• Vestibular migraine randomized trial: Kirazli and colleagues randomized 40 adults with definite vestibular migraine. Both groups completed four weeks of home VRT; one group also received eight supervised, clinic-based virtual-reality sessions. The added VR group had greater improvement in dizziness-related disability, dizziness severity and selected limits-of-stability measures. There was no between-group difference for the sensory-organisation composite or most functional head-impulse outcomes. The sample was small, follow-up was short and the study does not apply to every cause of dizziness. Original journal DOI; PubMed 42618982.
• Small chronic-dizziness rehabilitation series: Hiraoka and colleagues reported early results from an individualised three-month programme in eight older adults with chronic dizziness. Disability, balance confidence, functional gait, dynamic gait and 10-metre walking measures improved, while Timed Up and Go did not improve significantly. The uncontrolled eight-person series is preliminary and cannot provide a population success rate. Original journal DOI; full journal article.

What if VRT is not helping?

Do not automatically increase repetitions or copy a different internet programme. Review may need to address:

• whether the original diagnosis is correct;
• whether BPPV or another treatable disorder is still present;
• whether the exercise type or dose matches the impairment;
• whether migraine, vision, neuropathy, blood pressure, medicine effects, anxiety or a central condition is contributing;
• whether the programme is causing unsafe symptom escalation or falls; and
• whether the chosen outcome measure reflects the patient’s actual goal.

Medicines and VRT

Some medicines are useful for acute nausea or a diagnosed condition. Long-term use of vestibular-suppressant medicines may interfere with compensation or increase sedation in some patients, but this does not justify a universal “first one to two weeks only” rule or a claimed 20–30% reduction in rehabilitation success. Medication decisions belong with the prescribing clinician. Do not stop a prescribed medicine because of an online rehabilitation article.

Red flags: seek urgent assessment

Routine VRT is not the next step when new dizziness or imbalance occurs with:

• facial droop, new weakness or numbness, slurred speech or confusion;
• new double vision, collapse, fainting, chest pain or a severe new headache;
• sudden hearing loss;
• inability to stand or walk safely, repeated vomiting or dehydration; or
• a major fall, head injury or a continuous episode very different from previous symptoms.

Frequently asked questions

What is the average vestibular rehabilitation success rate?

Research supports VRT for diagnosed peripheral vestibular hypofunction, but the studies do not establish one average percentage that applies across diagnoses, programmes and outcome measures. Ask what outcome is being measured and in which patient group.

Am I too old to benefit from VRT?

No fixed age cutoff is supported. The 2022 guideline recommends offering VRT to older adults with appropriate diagnoses and expects good outcomes, while adapting the programme for fall risk, vision, neuropathy, cognition and other health conditions.

Can chronic dizziness still improve?

Yes, chronic peripheral vestibular hypofunction can improve with appropriate rehabilitation. Longer symptom duration should prompt careful assessment, but it should not be converted into a fixed “late treatment” penalty or used to deny treatment.

Is VRT the same as an Epley manoeuvre?

No. Epley is a canal-repositioning manoeuvre used mainly for confirmed posterior-canal BPPV. VRT is an individualised exercise programme used for selected gaze, balance, motion-sensitivity and functional impairments.

Should VRT make me very dizzy?

Some programmes use controlled, brief symptom provocation, but severe or prolonged worsening, repeated vomiting, unsafe walking, falls or new neurological symptoms require reassessment. Exercise intensity should be prescribed and progressed safely.

Assessment at Prime ENT Center, Hardoi

Assessment starts with the symptom pattern and examination. Positional, hearing or vestibular tests are selected only when they are likely to clarify the diagnosis, identify a safety concern or change management. Not every patient needs every test, and not every patient with dizziness needs VRT.

Appointments: 7393062200 (Call/WhatsApp)

Related guides

• Vestibular rehabilitation therapy guide
• Vestibular rehabilitation after neuritis
• BPPV: diagnosis and treatment
• Vestibular migraine guide
• Vertigo red-flag check

References

1. Hall CD, et al. Vestibular Rehabilitation for Peripheral Vestibular Hypofunction: An Updated Clinical Practice Guideline. J Neurol Phys Ther. 2022;46(2):118–177. doi:10.1097/NPT.0000000000000382; PubMed.
2. McDonnell MN, Hillier SL. Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database Syst Rev. 2015;(1):CD005397. doi:10.1002/14651858.CD005397.pub4; PubMed.
3. Bhattacharyya N, et al. Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update). Otolaryngol Head Neck Surg. 2017;156(3_suppl):S1–S47. doi:10.1177/0194599816689667; PubMed.
4. Krebs DE, et al. Vestibular rehabilitation: useful but not universally so. Otolaryngol Head Neck Surg. 2003;128(2):240–250. doi:10.1067/mhn.2003.72; PubMed.
5. Giray M, et al. Randomized controlled trial of vestibular rehabilitation in chronic unilateral vestibular dysfunction. Arch Phys Med Rehabil. 2009;90(8):1325–1331. doi:10.1016/j.apmr.2009.01.032; PubMed.
6. Kirazli G, et al. Virtual Reality-Based Vestibular Rehabilitation for Vestibular Migraine: A Randomized Trial. Laryngoscope. Published 19 August 2026. doi:10.1002/lary.70814; PubMed.
7. Hiraoka K, et al. Introduction and Early Results of Vestibular Rehabilitation in Collaboration with Rehabilitation Professionals. Equilibrium Research. 2026;85(3):149–156. doi:10.3757/jser.85.149; full article.

Medical disclaimer: This article provides general education and is not a diagnosis, individual exercise prescription, treatment guarantee or clearance for driving or safety-critical work. Seek urgent care for emergency warning signs and consult a qualified clinician for a diagnosis-specific plan.